Cargando…

Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease

OBJECTIVE: We assessed the effect of canagliflozin, an sodium-glucose co-transporter type-2 inhibitor, on hepatic steatosis using three imaging modalities: magnetic resonance imaging (MRI), computed tomography, and transient elastography. We further determined factors associated with improving hepat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimiya, Noriko, Tajima, Kazuki, Imajo, Kento, Kameda, Akiko, Yoshida, Eiko, Togashi, Yu, Aoki, Kazutaka, Inoue, Tomio, Nakajima, Atsushi, Utsunomiya, Daisuke, Terauchi, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627812/ https://www.ncbi.nlm.nih.gov/pubmed/33994437 http://dx.doi.org/10.2169/internalmedicine.7134-21

Ejemplares similares

Are Platelets Count Useful for Detecting the Grade of Steatosis?
por: Imajo, Kento, et al.
Publicado: (2015)

Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906
por: Tajima, Kazuki, et al.
Publicado: (2017)

AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration
por: Tajima, Kazuki, et al.
Publicado: (2013)

Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor
por: Okuyama, Tomoko, et al.
Publicado: (2020)

Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility
por: Kato, Shingo, et al.
Publicado: (2019)

Glucokinase Activation Ameliorates ER Stress–Induced Apoptosis in Pancreatic β-Cells
por: Shirakawa, Jun, et al.
Publicado: (2013)

DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acid
por: Shirakawa, Jun, et al.
Publicado: (2016)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
por: Beyer, Cayden, et al.
Publicado: (2021)

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Nogami, Asako, et al.
Publicado: (2023)

Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets
por: Okuyama, Tomoko, et al.
Publicado: (2017)

Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance
por: Masuda, Kiyomi, et al.
Publicado: (2011)

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
por: Zuo, Qingjuan, et al.
Publicado: (2022)

Quantitative analysis of vascular signs on early postmortem multi-detector computed tomography
por: Torimoto, Izumi, et al.
Publicado: (2014)

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
por: Shirakawa, Jun, et al.
Publicado: (2011)

Role of insulin receptor substrate‐1 for diethylnitrosamine plus high‐fat diet‐induced hepatic tumorigenesis in mice
por: Zolzaya, Khadbaatar, et al.
Publicado: (2014)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study
por: Aoki, Kazutaka, et al.
Publicado: (2017)

Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects
por: Kyohara, Mayu, et al.
Publicado: (2020)

Impact of glucose tolerance on the severity of non‐alcoholic steatohepatitis
por: Nakamura, Akinobu, et al.
Publicado: (2011)

Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease
por: Maruyama, Takashi, et al.
Publicado: (2019)

Correction to: A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes
por: Kimura, Masayo, et al.
Publicado: (2018)

A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes
por: Kimura, Masayo, et al.
Publicado: (2018)

Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
por: Hao, Zirui, et al.
Publicado: (2022)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

Comparison of Plasma Glucose and Gut Hormone Levels Between Drinking Enteral Formula Over a Period of 5 and 20 Minutes in Japanese Patients With Type 2 Diabetes: A Pilot Study
por: Kamiko, Kazunari, et al.
Publicado: (2016)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study
por: Kyohara, Mayu, et al.
Publicado: (2022)

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program
por: Weir, Matthew R, et al.
Publicado: (2020)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution
por: Nozaki, Yuichi, et al.
Publicado: (2015)

Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model
por: Nozaki, Yuichi, et al.
Publicado: (2015)

Crystal structure of canagliflozin hemihydrate
por: Liu, Kai-Hang, et al.
Publicado: (2016)

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study
por: Cho, Kyu Yong, et al.
Publicado: (2021)

Superior mesenteric artery embolism associated with Cisplatin-induced aortic thrombosis
por: Aoki, Ryo, et al.
Publicado: (2023)

Effect of Caloric Intake 25 or 30 kcal/kg/day on the Glycemic Control in Obese Patients With Type 2 Diabetes
por: Masuda, Kiyomi, et al.
Publicado: (2013)

COVID-19 pneumonia: infection control protocol inside computed tomography suites
por: Nakajima, Kento, et al.
Publicado: (2020)

Common and uncommon vascular injuries and endovascular treatment associated with pelvic blunt trauma: a real-world experience
por: Aoki, Ryo, et al.
Publicado: (2022)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rraotu7hs1nduj2tjq043hfb2h